Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-048419
Filing Date
2017-08-10
Accepted
2017-08-10 16:18:52
Documents
2
Period of Report
2017-08-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1562
2 POA DOCUMENT poa.txt EX-24.3_739893 3943
  Complete submission text file 0001209191-17-048419.txt   6877
Mailing Address 1301 SECOND AVE., SUITE 4200 SEATTLE WA 98101
Business Address
LASEZKAY GEORGE M (Reporting) CIK: 0001020514 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37783 | Film No.: 171021683

Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Issuer) CIK: 0001539029 (see all company filings)

EIN.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations